Showing results (61-70 of 705) with videos related to
Sort By:
Pageof 71
Journal of Bioscience and Bioengineering|June 28, 2020
Enzymatic hydrolysis and extraction of ginsenoside recovered from deep eutectic solvent-salt aqueous two-phase systemXin Han, Weina Li, Xiaoxuan Ma, et al.Pathology, Research and Practice|December 31, 2018
FBXL3 is regulated by miRNA-4735-3p and suppresses cell proliferation and migration in non-small cell lung cancerDazhong Wang, Xin Han, Chan Li, et al.Pharmacology & Therapeutics|December 15, 2020
Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosisXin Han, YanLing Wu, Qiao Yang, et al.Allergologia Et Immunopathologia|May 9, 2022
Dexmedetomidine reduces dextran sulfate sodium (DSS)-induced NCM460 cell inflammation and barrier damage by inhibiting RhoA/ROCK signaling pathwayXin Han, Yini Wu, Yongwei Zhuang, et al.Frontiers in Public Health|March 20, 2023
Mechanisms influencing the factors of urban built environments and coronavirus disease 2019 at macroscopic and microscopic scales: The role of citiesLonghao Zhang, Xin Han, Jun Wu, et al.Frontiers in Public Health|November 5, 2024
Infection risk factor measurement based on spatial and temporal distribution of COVID-19 nucleic acid test sites: an example from ShenzhenLei Wang, Longhao Zhang, Tianlin Zhang, et al.ACS Nano|November 28, 2024
Nanomaterials in Organoids: From Interactions to Personalized MedicineYing Shi, Xin Han, Siyi Zou, et al.African Journal of Reproductive Health|November 26, 2025
Food security, malnutrition, and obesity in India: A correlational studyShengbao Di, Zhikun Peng, Yuefei Yu, et al.Journal of Molecular Histology|May 14, 2013
Loss of RUNX3 expression may contribute to poor prognosis in patients with chondrosarcomaZhe Jin, Ya-Xin Han, Xiao-Rui HanCancer Biotherapy & Radiopharmaceuticals|June 20, 2013
Downregulated RhoBTB2 expression contributes to poor outcome in osteosarcoma patientsZhe Jin, Ya-Xin Han, Xiao-Rui HanPageof 71